key: cord-0892050-a9tc7v2q
authors: Borucki, Robert; Concha, Josef Symon S.; Burroughs, Julie; Okawa, Joyce; Werth, Victoria P.
title: Managing interventional clinical trials in the setting of COVID-19: Experience in an autoimmune skin disease unit
date: 2020-12-22
journal: JAAD international
DOI: 10.1016/j.jdin.2020.11.002
sha: 2a9f6e0d1ffad041a578a17b10aad5d9265270f2
doc_id: 892050
cord_uid: a9tc7v2q

nan

Other specialties, such as oncology, also continued in-person visits for essential study 71

procedures, though opted for telemedicine when possible. 1 Although the use of teledermatology 72

in clinical trials could be favorable during a pandemic, this approach needs further investigation. 

Adapting to a Pandemic -Conducting Oncology Trials 83 during the SARS-CoV-2 Pandemic

Inter-rater reliability 85 of cutaneous sarcoidosis assessment tools via remote photographic assessment

Quality of life in 88 cutaneous lupus erythematosus